You can’t fix what you don’t know is broken. Improving your grow harvest after harvest comes by understanding what aspects of your garden need attention. Having the right sensors and controls can give you the data needed to dial in the fire. From PPM to PPFD find out how to gain control of your grow with our expert panel.
The psychedelic “Renaissance” is well underway, and yet access to psychedelic therapies are still highly restricted and unavailable to most patients. This panel of Canadian psychedelic researchers and business leaders will discuss obstacles to access and how to overcome them, with a focus on current and upcoming studies and product development, regulatory changes, and evidence-based psychedelic-assisted treatments.
Moderated by Phillipe Lucas, PhD
This presentation will highlight the primary findings of the Canadian Psychedelic Survey (CPS), the most comprehensive survey of Canadian Psychedelic Use to date. CPS took place in January 2022, with 2393 adult respondents, and during this session we’ll learn who uses psychedelics in Canada, and explore patterns of use of 11 common psychedelics, as well as co-use with other substances. We’ll also explore peak positive and negative experiences and associated outcomes, micro vs. macro use, and review primary motivations for both recreational and medical use.”
Some jurisdictions have already moved towards legalization of medical use of psychedelics. The wellness community, investors and researchers are starting to think positively about imminent wide acceptance. Up that’s. Upcoming breakthroughs may involve core challenges, or changes to existing legislation. Canada has already opened the door for access to end of life care, and therapist are seeking to expand on the latitude they’ve been given. Once psychedelic prohibition is passed then a full fledged regulatory landscape over place at, Covering intellectual property, inspection, quality control, distribution, etc. This session will look ahead to a legal regulated future for psychedelics.
Moderated by Lucas McCann – Canndelta
This presentation will explore both the psychedelic research Renaissance and analysis of the pending legalization of psychedelics from a business perspective in Canada and internationally.
Moderated by Av Singh
Moderated by Lucas McCann – Canndelta
We still need to understand the therapeutic benefits of select compounds such as psilocybin, ketamine, ibogaine, LSD, DMT, MDMA, peyote, cannabis and even more types of plant medicine that we are still learning about in the mainstream. This panel explores some of the options available for those who may want to consider psychedelic therapy.
Moderated by. Marcus Roggen
With psychedelics more and more often in the news and represented in media, there is much to learn and understand within the topic of psychedelics as a whole. This session is intended to give attendees an overview of the Psychedelic space in Canada and touch on what the current Psychedelic landscape looks like today touching on psilocybin, ketamine, ibogaine, LSD, DMT, MDMA, peyote, ayahuasca, cannabis and more.
Moderated by Cy Williams
Recent Comments